Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Profile Avatar - Palmy Investing

Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, …

Medical - Devices
CN, Wuhan [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. has no acquisition track records yet.

M&A Deals · History

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. has no acquisition track records yet.

M&A Deals · Within Industry

No current deals within Medical - Devices Industry.

M&A Deals · Latest

Act, dont react; Track the most urgent M&A deals across all industries

Details
Owens Corning
Debt
Agg. Maximum Price
$373,155,000.00
Details
?
Equity
Agg. Maximum Price
$n/a
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
?
Equity
Agg. Maximum Price
$2,264,484.00
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
?
Equity
Agg. Maximum Price
$381.73
Details
?
Equity
Agg. Maximum Price
$7,657,428.54
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
?
Equity
Agg. Maximum Price
$19,377,844.50
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00
End of 002932.SZ's Analysis
CIK: - CUSIP: - ISIN: CNE1000033Q7 LEI: - UEI: -
Secondary Listings
002932.SZ has no secondary listings inside our databases.